Related Experiment Videos
Predictive value of urinalysis parameters for risk stratification of Staphylococcus aureus bacteremia in patients
Fatih Çubuk1, Özlem Aldemir2, Murtaza Öz3
1Department of Medical Microbiology, Sivas State Hospital, Sivas, Türkiye.
Aims:
Excluding bacteremia is clinically important in patients with Staphylococcus aureus bacteriuria (SABU), yet reliable predictors of concomitant S. aureus bacteremia (SAB) remain insufficiently defined. This study aimed to evaluate whether routine urinalysis parameters can predict concomitant SAB in patients with SABU.
Methods:
This retrospective cohort study included 82 patients with SABU. Demographic characteristics, urinalysis findings, inflammatory markers, and blood culture results were analyzed. Receiver operating characteristic (ROC) curve analysis and multivariate logistic regression were performed to identify predictors of SAB.
Results:
Concomitant SAB was detected in 29 patients (35.4%). Urinary bacterial count (31 vs 1/high-power field (HPF)) and erythrocyte count (39 vs 8/HPF) were significantly higher in bacteremic patients, together with elevated C-reactive protein (CRP) levels (all p < 0.05). ROC analysis identified an optimal cutoff value of 11/HPF for urinary bacterial count, with 82.8% sensitivity, 81.1% specificity, and a negative predictive value of 89.6% (AUC: 0.867). In multivariate analysis, urinary bacterial count, age, and CRP level remained independently associated with concomitant SAB.
Conclusions:
In conclusion, increased urinary bacterial count was associated with concomitant SAB and demonstrated a high negative predictive value for excluding bacteremia. Routine urinalysis parameters may contribute to early risk stratification in patients with SABU.
Related Concept Videos
Urine Studies II: Urine Culture and Sensitivity Test
Urine Studies I: Urinalysis
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection II: Pathophysiology